[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 447
Citations 0
News From the Food and Drug Administration
January 5, 2016

More Oversight Needed for LDTs

JAMA. 2016;315(1):20. doi:10.1001/jama.2015.17506

The FDA made its case for greater regulatory authority over laboratory developed tests (LDTs) in a recent report that details 20 incidents in which the tests were linked with patient harm (http://1.usa.gov/1PL0iot).

Laboratory developed tests are considered a subset of in vitro diagnostics, which the FDA has regulated as medical devices since 1976. In contrast to diagnostic tests made by a conventional manufacturer and used by many laboratories, LDTs are designed, manufactured, and used in a single laboratory.

First Page Preview View Large
First page PDF preview
First page PDF preview